Clinical trial · Interventional
Effects, Metabolic Mechanisms and Predictors of Response to Acupuncture in Treating Psychoneurological Symptoms Among Breast Cancer Survivors
NCT07695948CI-TRIAL-00117749not yet recruitingPhase 3ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to examine the effect, mediators and predictors of treatment response of acupuncture in treating the psychoneurological symptom cluster (pain, fatigue, sleep disturbance) among breast cancer survivors.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Acupuncture | Behavioral | — | UNRESOLVED |
| Sham acupuncture | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- EXPERIMENTAL
- label
- Acupuncture group
- interventionNames
- Behavioral: Acupuncture
- type
- SHAM_COMPARATOR
- label
- Sham acupuncture group
- interventionNames
- Behavioral: Sham acupuncture
- type
- NO_INTERVENTION
- label
- Usual care group
- description
- Participants will continue to receive their usual care.
Primary outcomes (1)
- measure
- The psychoneurological symptom cluster
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * ≥ 18 years of age * With histologically confirmed Stage 0-III ER/PR-positive HER2-negative breast cancer * Currently receiving adjuvant endocrine therapy * Completed their primary cancer treatment (e.g., surgery, radiotherapy, chemotherapy) at least 3 months prior to recruitment * Acupuncture-naïve * Have self- reported pain, fatigue, and sleep disturbance in the last month with an average severity rating ≥ 3 (0-10 numeric rating scale) for at least 2 of the 3 symptoms. Exclusion Criteria: * Taking methylsulfonylmethane or glutathione supplements * Physically or cognitively unable to complete the study procedures * Pregnant
References
Publications (0)
Data not yet available
No reference posted for this study.